It would be of great interest to investigate whether selective inhibition of Brd4 or macrophage Brd4 could affect Gdf3-ALK7 signaling pathway and also be an effective approach to treat obesity and insulin resistance. Here, ACVR1C is linked to obesity due to melanocortin 4 receptor deficiency.